Zobrazeno 1 - 1
of 1
pro vyhledávání: '"C.M. Congedo"'
Publikováno v:
European Psychiatry, Vol 65, Pp S884-S884 (2022)
Introduction Esketamine is a novel antidepressant approved by the FDA in 2019 in the form of an intranasal spray, recommended for Treatment-Resistant Depression (TRD). The intranasal spray system appears to be more manageable than intravenous ketamin
Externí odkaz:
https://doaj.org/article/265fb3f4329b476c960f128974f26f0b
